CU Medical Systems씨유메디칼
115480 · KOSDAQ · ₩115480 · 씨유메디칼
₩2,020▲ ₩10 (0.50%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 55.6% | 59.1% | 53.0% | 48.8% | 52.0% | 52.2% |
| Operating margin | 24.0% | 22.4% | 19.2% | 11.8% | 23.0% | 20.3% |
| Net margin | 15.6% | 1.7% | −7.9% | −19.6% | 19.4% | −39.5% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +29.4% | +18.7% | −2.8% | −11.0% | +32.6% | — |
| Operating income growth | +38.3% | +38.6% | +57.9% | −54.2% | +50.2% | — |
| Net income growth | +1,085.5% | +125.6% | +60.9% | −190.2% | +165.1% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 15.0% | 1.4% | −5.7% | −14.6% | 17.0% | −28.6% |
| Return on assets | 5.8% | 0.8% | −3.3% | −9.4% | 11.4% | −19.4% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 75.2% | 67.0% | 74.6% | 58.0% | 49.5% | 48.6% |
| Net debt to equity | 16.0% | 19.7% | 22.9% | 23.7% | 19.9% | 3.4% |
| Current ratio | 117.4% | 483.9% | 360.7% | 125.2% | 288.8% | 326.7% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: CU Medical Systems / 씨유메디칼 / 115480 / KRX:115480
Source: KRX statistical information